| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 7.04T | 6.54T | 6.08T | 5.91T | 5.69T |
| Gross Profit | 3.38T | 3.16T | 2.93T | 2.72T | 2.80T |
| EBITDA | 999.92B | 1.74T | 1.64T | 1.75T | 1.73T |
| Net Income | 550.76B | 519.98B | 489.07B | 531.37B | 517.08B |
Balance Sheet | |||||
| Total Assets | 18.50T | 16.10T | 15.52T | 14.68T | 13.10T |
| Cash, Cash Equivalents and Short-Term Investments | 1.44T | 1.61T | 2.15T | 2.19T | 1.66T |
| Total Debt | 6.48T | 5.96T | 6.32T | 6.13T | 6.02T |
| Total Liabilities | 13.83T | 11.84T | 11.59T | 11.00T | 9.88T |
| Stockholders Equity | 2.96T | 2.74T | 2.38T | 2.22T | 1.96T |
Cash Flow | |||||
| Free Cash Flow | 823.29B | 621.21B | 685.62B | 546.53B | 506.83B |
| Operating Cash Flow | 1.39T | 1.37T | 1.24T | 1.16T | 1.22T |
| Investing Cash Flow | -1.12T | -971.93B | -893.40B | -123.87B | -950.57B |
| Financing Cash Flow | -288.99B | -979.68B | -391.30B | -526.17B | -312.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥559.13B | 22.73 | 15.67% | 1.31% | 9.02% | 21.15% | |
73 Outperform | ¥10.26T | 18.73 | ― | 3.99% | 7.55% | 3.27% | |
70 Outperform | ¥327.52B | 24.76 | 13.42% | 2.27% | 2.41% | 9.05% | |
62 Neutral | ¥3.24B | 11.24 | ― | ― | 8.20% | 2.55% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
57 Neutral | ¥12.74T | 11.58 | 11.22% | 3.36% | 5.14% | 5.49% | |
56 Neutral | ¥9.86T | 14.36 | 13.75% | 2.85% | 4.05% | 13.53% |